推荐产品
生物来源
rabbit
质量水平
100
500
偶联物
unconjugated
抗体形式
culture supernatant
抗体产品类型
primary antibodies
克隆
EP212, monoclonal
描述
For In Vitro Diagnostic Use in Select Regions (See Chart)
表单
buffered aqueous solution
种属反应性
human
包装
vial of 0.1 mL concentrate (386R-14)
vial of 0.5 mL concentrate (386R-15)
bottle of 1.0 mL predilute (386R-17)
vial of 1.0 mL concentrate (386R-16)
bottle of 7.0 mL predilute (386R-18)
制造商/商品名称
Cell Marque™
技术
immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:25-1:100
同位素/亚型
IgG
控制
rhabdomyosarcoma
运输
wet ice
储存温度
2-8°C
可视化
nuclear
基因信息
human ... MYOD1(4654)
一般描述
MyoD1, one of the MyoD family of myogenic helix-loop-helix transcription factors, combinedwith myogenin, plays a role in coordinating the differentiation of skeletal muscle. MyoD1 isexpressed in myoblasts before differentiation. Anti-MyoD1 immunostaining identifies cellscommitted to myogenesis in their earliest phase. In conjunction with other markers, antiMyoD1 may be used for the identification of rhabdomyosarcoma.
质量
 IVD |  IVD |  IVD |  RUO |
联系
MyoD1 Positive Control Slides, Product No. 386S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).
外形
Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide
制备说明
Download the IFU specific to your product lot and formatNote: This requires a keycode which can be found on your packaging or product label.
其他说明
For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com
法律信息
Cell Marque is a trademark of Merck KGaA, Darmstadt, Germany
未找到合适的产品？
试试我们的产品选型工具.
法规信息
监管及禁止进口产品
从最新的版本中选择一种：
分析证书(COA)
Lot/Batch Number
N J Sebire et al.
Journal of clinical pathology, 56(6), 412-416 (2003-06-05)
The diagnosis of paediatric solid tumours is often based on small tissue needle biopsies in which many different entities demonstrate a "small round cell tumour" phenotype and in which there may be insufficient tissue to allow the interpretation of diagnostic
Raffaella A Morotti et al.
The American journal of surgical pathology, 30(8), 962-968 (2006-07-25)
Immunohistochemistry remains the current ancillary method of choice in the pathologic evaluation of small blue round-cell tumors. In at least 20% of cases of rhabdomyosarcoma (RMS), it is considered an essential factor in the final and/or differential diagnosis of the
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门